| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |